Valuation : PolyPeptide Group AG

Market Cap 1.54B 1.79B 1.45B 1.32B 2.49B 170B 2.5B 17.17B 6.68B 86.43B 6.72B 6.58B 287B P/E 2026 *
49.2x
P/E 2027 * 29.6x
Enterprise Value 1.66B 1.92B 1.56B 1.42B 2.67B 182B 2.68B 18.42B 7.17B 92.7B 7.21B 7.05B 307B EV / Sales 2026 *
3.33x
EV / Sales 2027 * 2.95x
Free-Float
39.12%
Yield 2026 *
-
Yield 2027 * 0.09%
1 day-0.11%
1 week+0.11%
Current month-0.11%
1 month+0.46%
3 months+16.25%
6 months+71.21%
Current year+68.58%
1 week 43.95
Extreme 43.95
44.1
1 month 43.85
Extreme 43.85
44.1
Current year 23.1
Extreme 23.1
50.1
1 year 21.8
Extreme 21.8
50.1
3 years 13.22
Extreme 13.22
50.1
5 years 13.22
Extreme 13.22
147.4
10 years 13.22
Extreme 13.22
147.4
Manager TitleAgeSince
Chief Executive Officer 54 2023-04-11
Director of Finance/CFO 54 2024-01-01
Chief Tech/Sci/R&D Officer 54 -
Director TitleAgeSince
Director/Board Member 73 2005-12-31
Chairman 69 2021-03-31
Director/Board Member 62 2020-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
11/13/23 Buy 2,500 0.0075%
10/12/23 Buy 159,959 0.4829%
4/6/23 Buy 45,842 0.1384%
Change 5-day change 1-year change 3-year change Capi.($)
-0.11%+0.11%+61.47%+81.07% 1.8B
+0.28%-5.97%+58.34%+108.22% 1,031B
+2.01%-0.71%+53.07%+68.99% 641B
+1.39%-2.18%+23.57%+75.43% 453B
-1.50%-7.04%+33.55%+33.94% 349B
+6.25%+2.04%+28.97%+46.57% 290B
-0.07%-4.12%+0.95%+11.79% 252B
+1.92%-0.93%+52.28%+70.67% 232B
+0.51%-4.52%-19.50%-54.83% 201B
+2.45%+0.77%+32.71%+95.59% 181B
Average +1.44%-2.60%+32.54%+53.74% 363.16B
Weighted average by Cap. +1.60%-3.40%+38.40%+66.40%

Financials

2026 *2027 *
Net sales 498M 577M 468M 426M 802M 54.74B 806M 5.53B 2.15B 27.85B 2.17B 2.12B 92.33B 574M 665M 540M 492M 924M 63.11B 929M 6.38B 2.48B 32.11B 2.5B 2.44B 106B
Net income 25M 28.98M 23.52M 21.42M 40.29M 2.75B 40.51M 278M 108M 1.4B 109M 106M 4.64B 45M 52.17M 42.33M 38.56M 72.52M 4.95B 72.91M 500M 195M 2.52B 196M 192M 8.35B
Net Debt 112M 130M 105M 95.98M 180M 12.32B 181M 1.25B 485M 6.27B 487M 477M 20.78B 146M 169M 137M 125M 235M 16.06B 237M 1.62B 632M 8.17B 635M 622M 27.09B
Logo PolyPeptide Group AG
Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.
Employees
1,460
Date Price Change Volume
26-09-01 CHF 44.00 -0.11% 71,068
26-08-31 CHF 44.05 +0.11% 73,497
26-08-28 CHF 44.00 +0.11% 1,260,680
26-08-27 CHF 43.95 0.00% 54,987
26-08-26 CHF 43.95 0.00% 29,848
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
46.78EUR
Average target price
42.13EUR
Spread / Average Target
-9.93%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PPGN Stock